2024 Exhibitors Search
PLABiologics Co.,Ltd.
| Country | Korea, South |
|---|---|
| Address | |
| Tel (Rep.) | 031-881-7234 |
| Website | http://www.plabiologics.com |
Company Introduction
PLABiologics Co., Ltd. has been conducting research and development of therapies for metabolic and degenerative diseases using UNIPla®, a representative high-purity and high-quality mesenchymal stem cell, and SUNIPla®, a functionally enhanced placenta-derived mesenchymal stem cell, leveraging over 20 years of research results.
Promotional video
Exhibit Item
Cell and Gene Therapy based on Placenta-derived Mesenchymal Stem Cell
Exhibit Item Images
-
Product Name : UNIPla®-FUNIPla®-F: Cell Therapy for Polycystic Ovary Syndrome (PCOS) -
Product Name : UNIPla®-EUNIPla®-E: Cell Therapy for Macular Degeneration (MD) -
Product Name : SUNIPla®-MSUNIPla®-M: Functionally Enhanced Cell & Gene Therapy for Metabolic Dysfunction-associated Steatohepatitis (MASH)
-
Product Name : SUNIPla®-DESUNIPla®-DE: Functionally Enhanced Cell & Gene Therapy for Diabetic Retinopathy
Exhibit Description
[Platform Technology] 1. UNIPla®: Representative high purity and high quality mesenchymal stem cells derived from placental chorionic plate 2. SUNIPla®: Next generation cell and gene therapy ? Functionally enhanced placenta-derived mesenchymal stem cells
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.